Cav3.1

1

Berecki G et al. Mechanism of direct Cav2.2 channel block by the κ-opioid receptor agonist U50488H.
Neuropharmacology, 2016 May 28 , 109 (49-58).

2

Olamendi-Portugal T et al. Isolation, chemical and functional characterization of several new K(+)-channel blocking peptides from the venom of the scorpion Centruroides tecomanus.
Toxicon, 2016 Jun 1 , 115 (1-12).

3

Calhoun JD et al. Cacna1g is a genetic modifier of epilepsy caused by mutation of voltage-gated sodium channel Scn2a.
Epilepsia, 2016 Jun , 57 (e103-7).

4

Yang W et al. Cannabinoid receptor agonists modulate calcium channels in rat retinal müller cells.
Neuroscience, 2016 Jan 28 , 313 (213-24).

5

Elíes J et al. Regulation of the T-type Ca(2+) channel Cav3.2 by hydrogen sulfide: Emerging controversies concerning the role of H2 S in nociception.
J. Physiol. (Lond.), 2016 Jan 25 , ().

6

Pethő Z et al. The anti-proliferative effect of cation channel blockers in T lymphocytes depends on the strength of mitogenic stimulation.
Immunol. Lett., 2016 Feb 6 , 171 (60-69).

7

Wen X et al. Inhibitory gene expression of the Cav3.1 T-type calcium channel to improve neuronal injury induced by lidocaine hydrochloride.
Eur. J. Pharmacol., 2016 Feb 4 , ().

8

Raychaudhuri SK et al. KCa3.1(-/-) Mice Do Not Develop CIA: Regulatory Role for KCa3.1 in Autoimmune Arthritis.
J. Cell. Physiol., 2016 Feb 22 , ().

9

Choi JY et al. Role of protein kinase A and class II phosphatidylinositol 3-kinase C2β in the downregulation of KCa3.1 channel synthesis and membrane surface expression by lyso-globotriaosylceramide.
Biochem. Biophys. Res. Commun., 2016 Feb 19 , 470 (907-12).

10

Mattheij NJ et al. Survival protein anoctamin-6 controls multiple platelet responses including phospholipid scrambling, swelling, and protein cleavage.
FASEB J., 2016 Feb , 30 (727-37).

11

D'Alessandro G et al. KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment.
Oncotarget, 2016 Apr 16 , ().

12

Ohya S et al. Downregulation of the Ca(2+)-activated K(+) channel KC a3.1 by histone deacetylase inhibition in human breast cancer cells.
Pharmacol Res Perspect, 2016 Apr , 4 (e00228).

13

Ye F et al. The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases.
Toxins (Basel), 2016 , 8 ().

14

Salari A et al. Molecular Interactions between Tarantula Toxins and Low-Voltage-Activated Calcium Channels.
Sci Rep, 2016 , 6 (23894).

15

Siddiqui TA et al. Complex molecular and functional outcomes of single versus sequential cytokine stimulation of rat microglia.
J Neuroinflammation, 2016 , 13 (66).

16

Ohya S Physiological Role of K(+) Channels in the Regulation of T Cell Function.
Yakugaku Zasshi, 2016 , 136 (479-83).

17

Goedicke-Fritz S et al. Evidence for functional and dynamic microcompartmentation of Cav-1/TRPV4/K(Ca) in caveolae of endothelial cells.
Eur. J. Cell Biol., 2015 Jul-Sep , 94 (391-400).

18

Bhuyan R et al. Molecular dynamics of Kv1.3 ion channel and structural basis of its inhibition by scorpion toxin-OSK1 derivatives.
Biophys. Chem., 2015 Aug-Sep , 203-204 (1-11).

19

Sakkaki S et al. A role of T-type calcium channels in tonic-clonic seizures as revealed by the anticonvulsant properties of the blocker TTA-A2.
Neuropharmacology, 2015 Oct 9 , ().

20

Coutelier M et al. A Recurrent Mutation in CACNA1G Alters Cav3.1 T-Type Calcium-Channel Conduction and Causes Autosomal-Dominant Cerebellar Ataxia.
Am. J. Hum. Genet., 2015 Oct 6 , ().

21

Kim CH Cav3.1 T-type calcium channel modulates the epileptogenicity of hippocampal seizures in the kainic acid-induced temporal lobe epilepsy model.
Brain Res., 2015 Oct 5 , 1622 (204-16).

22

Zhang SX et al. [Effect of Kv1.3 and KCa3.1 potassium ion channels on the proliferation and migration of monocytes/macrophages].
Sheng Li Xue Bao, 2015 Oct 25 , 67 (505-12).

23

Andolfo I et al. Novel Gardos channel mutations linked to dehydrated hereditary stomatocytosis (xerocytosis).
Am. J. Hematol., 2015 Oct , 90 (921-6).

24

Park SJ et al. Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3.
Biochim. Biophys. Acta, 2015 Oct , 1848 (2092-100).

25

Harraz OF et al. CaV1.2/CaV3.x channels mediate divergent vasomotor responses in human cerebral arteries.
J. Gen. Physiol., 2015 May , 145 (405-18).

26

Jung S et al. Epileptic activity during early postnatal life in the AY-9944 model of atypical absence epilepsy.
Cell Calcium, 2015 May , 57 (376-84).

27

Curran J et al. Eps15 Homology Domain-containing Protein 3 Regulates Cardiac T-type Ca2+ Channel Targeting and Function in the Atria.
J. Biol. Chem., 2015 Mar 30 , ().

28

Zhang L et al. Lipopolysaccharides upregulate calcium concentration in mouse uterine smooth muscle cells through the T-type calcium channels.
Int. J. Mol. Med., 2015 Mar , 35 (784-90).

29

Dominguez Rieg JA et al. P2Y₂ receptor activation decreases blood pressure via intermediate conductance potassium channels and connexin 37.
Acta Physiol (Oxf), 2015 Mar , 213 (628-41).

30

Monteil A et al. Inhibition of Cav3.2 T-type Calcium Channels by Its Intracellular I-II Loop.
J. Biol. Chem., 2015 Jun 26 , 290 (16168-76).

31

Choi S et al. Altered thalamocortical rhythmicity and connectivity in mice lacking CaV3.1 T-type Ca2+ channels in unconsciousness.
Proc. Natl. Acad. Sci. U.S.A., 2015 Jun 23 , 112 (7839-44).

32

Zhou FJ et al. Two New Classes of T-Type Calcium Channel Inhibitors with New Chemical Scaffolds from Ganoderma cochlear.
Org. Lett., 2015 Jun 19 , 17 (3082-5).

33

Elíes J et al. H2S does not regulate proliferation via T-type Ca2+ channels.
Biochem. Biophys. Res. Commun., 2015 Jun 12 , 461 (659-64).

34

Tompkins JD et al. Nickel suppresses the PACAP-induced increase in guinea pig cardiac neuron excitability.
Am. J. Physiol., Cell Physiol., 2015 Jun 1 , 308 (C857-66).

35

Chang SC et al. N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.
FEBS J., 2015 Jun , 282 (2247-59).

36

Cain SM et al. Thalamocortical neurons display suppressed burst-firing due to an enhanced Ih current in a genetic model of absence epilepsy.
Pflugers Arch., 2015 Jun , 467 (1367-82).

37

Henríquez C et al. The calcium-activated potassium channel KCa3.1 plays a central role in the chemotactic response of mammalian neutrophils.
Acta Physiol (Oxf), 2015 Jul 3 , ().

38

Friebel K et al. Functional role of the KCa3.1 potassium channel in synovial fibroblasts from rheumatoid arthritis patients.
J. Cell. Physiol., 2015 Jul , 230 (1677-88).

39

Mishra RC et al. Inhibition of Myogenic Tone in Rat Cremaster and Cerebral Arteries by SKA-31, an Activator of Endothelial KCa2.3 and KCa3.1 Channels.
J. Cardiovasc. Pharmacol., 2015 Jul , 66 (118-27).

40

Chen YJ et al. Blood-brain barrier KCa3.1 channels: evidence for a role in brain Na uptake and edema in ischemic stroke.
Stroke, 2015 Jan , 46 (237-44).

41

Cretoiu SM et al. Isolated human uterine telocytes: immunocytochemistry and electrophysiology of T-type calcium channels.
Histochem. Cell Biol., 2015 Jan , 143 (83-94).

42

Wang Q et al. [Effects of bisphenol A on voltage-dependent T-type calcium channels in mouse testis and epididymis, and the role of estrogen receptors].
Wei Sheng Yan Jiu, 2015 Jan , 44 (23-7).

43

Huang C et al. KCa3.1: a new player in progressive kidney disease.
Curr. Opin. Nephrol. Hypertens., 2015 Jan , 24 (61-6).

44

Hansen PB Functional importance of T-type voltage-gated calcium channels in the cardiovascular and renal system: news from the world of knockout mice.
Am. J. Physiol. Regul. Integr. Comp. Physiol., 2015 Feb 15 , 308 (R227-37).

45

Yu H et al. Noradrenaline upregulates T-type calcium channels in rat pinealocytes.
J. Physiol. (Lond.), 2015 Feb 15 , 593 (887-904).

46

Oliván-Viguera A et al. A novel pan-negative-gating modulator of KCa2/3 channels, fluoro-di-benzoate, RA-2, inhibits endothelium-derived hyperpolarization-type relaxation in coronary artery and produces bradycardia in vivo.
Mol. Pharmacol., 2015 Feb , 87 (338-48).

47

Gasparoli L et al. New pyrimido-indole compound CD-160130 preferentially inhibits the KV11.1B isoform and produces antileukemic effects without cardiotoxicity.
Mol. Pharmacol., 2015 Feb , 87 (183-96).

48

Fukunaga K [Cognitive Function and Calcium. Cognitive improvement through T type calcium channel stimulation].
Clin Calcium, 2015 Feb , 25 (247-54).

49

Littlechild R et al. Inhibition of KCa3.1 by depolarisation and 2-aminoethoxydiphenyl borate (2-APB) during Ca²⁺ release activated Ca²⁺ (CRAC) entry in human erythroleukemia (HEL) cells: Implications for the interpretation of 2-APB inhibition of CRAC entry.
Cell Calcium, 2015 Feb , 57 (76-88).

50

Turner RW et al. Neuronal expression of the intermediate conductance calcium-activated potassium channel KCa3.1 in the mammalian central nervous system.
Pflugers Arch., 2015 Feb , 467 (311-28).

51

Choi JY et al. Lyso-globotriaosylceramide downregulates KCa3.1 channel expression to inhibit collagen synthesis in fibroblasts.
Biochem. Biophys. Res. Commun., 2015 Dec 25 , 468 (883-8).

52

Wen X et al. [Role of calmodulin-dependent protein kinase II in bupivacaine hydrochloride-induced injury of SH-SY5Y cells].
Nan Fang Yi Ke Da Xue Xue Bao, 2015 Aug , 35 (1133-6).

53

Tomasova L et al. Effects of AP39, a novel triphenylphosphonium derivatised anethole dithiolethione hydrogen sulfide donor, on rat haemodynamic parameters and chloride and calcium Cav3 and RyR2 channels.
Nitric Oxide, 2015 Apr 30 , 46 (131-44).

54

Staehlke S et al. Intracellular calcium dynamics dependent on defined microtopographical features of titanium.
Biomaterials, 2015 Apr , 46 (48-57).

55

Zhang C et al. 17β-Estradiol increases persistent Na(+) current and excitability of AVPV/PeN Kiss1 neurons in female mice.
Mol. Endocrinol., 2015 Apr , 29 (518-27).

56

Freise C et al. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Liver Int., 2015 Apr , 35 (1244-52).

57

Waeckel L et al. Preserved regulation of renal perfusion pressure by small and intermediate conductance KCa channels in hypertensive mice with or without renal failure.
Pflugers Arch., 2015 Apr , 467 (817-31).

58

Mesirca P et al. Functional role of voltage gated Ca(2+) channels in heart automaticity.
Front Physiol, 2015 , 6 (19).

59

Elíes J et al. Inhibition of T-type Ca(2+) Channels by Hydrogen Sulfide.
Adv. Exp. Med. Biol., 2015 , 860 (353-60).

60

Duckles H et al. T-Type Ca(2+) Channel Regulation by CO: A Mechanism for Control of Cell Proliferation.
Adv. Exp. Med. Biol., 2015 , 860 (291-300).

61

Lin H et al. Lentiviral shRNA against KCa3.1 inhibits allergic response in allergic rhinitis and suppresses mast cell activity via PI3K/AKT signaling pathway.
Sci Rep, 2015 , 5 (13127).

62

Duffy SM et al. Orai/CRACM1 and KCa3.1 ion channels interact in the human lung mast cell plasma membrane.
Cell Commun. Signal, 2015 , 13 (32).

63

Arthur GK et al. KCa3.1 K+ Channel Expression and Function in Human Bronchial Epithelial Cells.
PLoS ONE, 2015 , 10 (e0145259).

64

Bartok A et al. An engineered scorpion toxin analogue with improved Kv1.3 selectivity displays reduced conformational flexibility.
Sci Rep, 2015 , 5 (18397).

65

Nakamura K et al. Proinflammatory Cytokines and Potassium Channels in the Kidney.
Mediators Inflamm., 2015 , 2015 (362768).

66

Calderón-Rivera A et al. Regulation of neuronal cav3.1 channels by cyclin-dependent kinase 5 (Cdk5).
PLoS ONE, 2015 , 10 (e0119134).

67

Penna A et al. KCa3.1-Dependent Hyperpolarization Enhances Intracellular Ca2+ Signaling Induced by fMLF in Differentiated U937 Cells.
PLoS ONE, 2015 , 10 (e0139243).

68

Ju CH et al. Blockade of KCa3.1 Attenuates Left Ventricular Remodeling after Experimental Myocardial Infarction.
Cell. Physiol. Biochem., 2015 , 36 (1305-15).

69

Wang CY et al. Meta-Analysis of Public Microarray Datasets Reveals Voltage-Gated Calcium Gene Signatures in Clinical Cancer Patients.
PLoS ONE, 2015 , 10 (e0125766).

70

Cahalan SM et al. Piezo1 links mechanical forces to red blood cell volume.
Elife, 2015 , 4 ().

71

Watanabe M et al. Expression and Regulation of Cav3.2 T-Type Calcium Channels during Inflammatory Hyperalgesia in Mouse Dorsal Root Ganglion Neurons.
PLoS ONE, 2015 , 10 (e0127572).

72

Rabjerg M et al. High expression of KCa3.1 in patients with clear cell renal carcinoma predicts high metastatic risk and poor survival.
PLoS ONE, 2015 , 10 (e0122992).

73

Harraz OF et al. Ca(V)3.2 channels and the induction of negative feedback in cerebral arteries.
Circ. Res., 2014 Sep 12 , 115 (650-61).

74

Chevalier M et al. T-type calcium channels are involved in hypoxic pulmonary hypertension.
Cardiovasc. Res., 2014 Sep 1 , 103 (597-606).

75

Bartok A et al. Margatoxin is a non-selective inhibitor of human Kv1.3 K(+) channels.
Toxicon, 2014 Sep , 87 (6-16).

76

Cazade M et al. 5,6-EET potently inhibits T-type calcium channels: implication in the regulation of the vascular tone.
Pflugers Arch., 2014 Sep , 466 (1759-68).

77

Ongerth T et al. Targeting of microglial KCa3.1 channels by TRAM-34 exacerbates hippocampal neurodegeneration and does not affect ictogenesis and epileptogenesis in chronic temporal lobe epilepsy models.
Eur. J. Pharmacol., 2014 Oct 5 , 740 (72-80).

78

Wong R et al. PKA reduces the rat and human KCa3.1 current, CaM binding, and Ca2+ signaling, which requires Ser332/334 in the CaM-binding C terminus.
J. Neurosci., 2014 Oct 1 , 34 (13371-83).

79

Huang C et al. Role of the potassium channel KCa3.1 in diabetic nephropathy.
Clin. Sci., 2014 Oct , 127 (423-33).

80

Ranzato E et al. Epigallocatechin-3-gallate elicits Ca2+ spike in MCF-7 breast cancer cells: essential role of Cav3.2 channels.
Cell Calcium, 2014 Oct , 56 (285-95).

81

Chen R et al. Mechanisms and energetics of potassium channel block by local anesthetics and antifungal agents.
Biochemistry, 2014 Nov 4 , 53 (6786-92).

82

Hansen LK The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitis.
Dan Med J, 2014 Nov , 61 (B4946).

83

Koch Hansen L et al. Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis.
J Crohns Colitis, 2014 Nov , 8 (1378-91).

84

Hu CW et al. Bone morphogenetic protein-4 induces upregulation of Cav3.1 Ca²⁺ channels in HL-1 atrial myocytes.
Pflugers Arch., 2014 Nov , 466 (2049-57).

85

Ohya S et al. Upregulation of KCa3.1 K(+) channel in mesenteric lymph node CD4(+) T lymphocytes from a mouse model of dextran sodium sulfate-induced inflammatory bowel disease.
Am. J. Physiol. Gastrointest. Liver Physiol., 2014 May 15 , 306 (G873-85).

86

González-Ramírez R et al. Transcription factor Sp1 regulates T-type Ca(2+) channel CaV 3.1 gene expression.
J. Cell. Physiol., 2014 May , 229 (551-60).

87

Climent B et al. Effects of obesity on vascular potassium channels.
Curr Vasc Pharmacol, 2014 May , 12 (438-52).

88

Perissinotti PP et al. Down-regulation of endogenous KLHL1 decreases voltage-gated calcium current density.
Cell Calcium, 2014 May , 55 (269-80).

89

Rice RA et al. Age-related downregulation of the CaV3.1 T-type calcium channel as a mediator of amyloid beta production.
Neurobiol. Aging, 2014 May , 35 (1002-11).

90

Lee JH et al. Synthesis and biological evaluation of 1-(isoxazol-5-ylmethylaminoethyl)-4-phenyl tetrahydropyridine and piperidine derivatives as potent T-type calcium channel blockers with antinociceptive effect in a neuropathic pain model.
Eur J Med Chem, 2014 Mar 3 , 74 (246-57).

91

Panyi G et al. Ion channels and anti-cancer immunity.
Philos. Trans. R. Soc. Lond., B, Biol. Sci., 2014 Mar 19 , 369 (20130106).

92

Dziegielewska B et al. T-type Ca2+ channel inhibition induces p53-dependent cell growth arrest and apoptosis through activation of p38-MAPK in colon cancer cells.
Mol. Cancer Res., 2014 Mar , 12 (348-58).

93

Bae H et al. The stimulating effects of nitric oxide on intermediate conductance Ca²⁺-activated K⁺ channels in human dermal fibroblasts through PKG pathways but not the PKA pathways.
Chin J Physiol, 2014 Jun 30 , 57 (137-51).

94

Coleman N et al. New Positive KCa Channel Gating Modulators with Selectivity for KCa3.1.
Mol. Pharmacol., 2014 Jun 23 , ().

95

Turner KL et al. A proinvasive role for the Ca(2+) -activated K(+) channel KCa3.1 in malignant glioma.
Glia, 2014 Jun , 62 (971-81).

96

Luna-Ramírez K et al. Structure, molecular modeling, and function of the novel potassium channel blocker urotoxin isolated from the venom of the Australian scorpion Urodacus yaschenkoi.
Mol. Pharmacol., 2014 Jul , 86 (28-41).

97

Freise C et al. Inhibition of vascular calcification by block of intermediate conductance calcium-activated potassium channels with TRAM-34.
Pharmacol. Res., 2014 Jul , 85 (6-14).

98

Yu Z et al. Targeted inhibition of KCa3.1 attenuates TGF-β-induced reactive astrogliosis through the Smad2/3 signaling pathway.
J. Neurochem., 2014 Jul , 130 (41-9).

99

Martinsen A et al. Myosin light chain kinase controls voltage-dependent calcium channels in vascular smooth muscle.
Pflugers Arch., 2014 Jul , 466 (1377-89).

100

Turner RW et al. T-type channels buddy up.
Pflugers Arch., 2014 Jan 11 , ().

101

Qian X et al. Positive feedback regulation of agonist-stimulated endothelial Ca2+ dynamics by KCa3.1 channels in mouse mesenteric arteries.
Arterioscler. Thromb. Vasc. Biol., 2014 Jan , 34 (127-35).

102

Choi S et al. Globotriaosylceramide induces lysosomal degradation of endothelial KCa3.1 in fabry disease.
Arterioscler. Thromb. Vasc. Biol., 2014 Jan , 34 (81-9).

103

Cui Y et al. Exposure to extremely low-frequency electromagnetic fields inhibits T-type calcium channels via AA/LTE4 signaling pathway.
Cell Calcium, 2014 Jan , 55 (48-58).

104

Zhang J et al. Overexpression of myocardin induces partial transdifferentiation of human-induced pluripotent stem cell-derived mesenchymal stem cells into cardiomyocytes.
Physiol Rep, 2014 Feb 1 , 2 (e00237).

105

Michaela P et al. Bisphenol A differently inhibits CaV3.1, Ca V3.2 and Ca V3.3 calcium channels.
Naunyn Schmiedebergs Arch. Pharmacol., 2014 Feb , 387 (153-63).

106

Wang Y et al. [Ca(2+)-activated K(+) channel switching in smooth muscle participates in atherosclerosis development in diabetic rats].
Nan Fang Yi Ke Da Xue Xue Bao, 2014 Feb , 34 (188-92).

107

Garneau L et al. Aromatic-aromatic interactions between residues in KCa3.1 pore helix and S5 transmembrane segment control the channel gating process.
J. Gen. Physiol., 2014 Feb , 143 (289-307).

108

Huang C et al. Inhibition of KCa3.1 suppresses TGF-β1 induced MCP-1 expression in human proximal tubular cells through Smad3, p38 and ERK1/2 signaling pathways.
Int. J. Biochem. Cell Biol., 2014 Feb , 47 (1-10).

109

Huang C et al. KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis.
Nephrol. Dial. Transplant., 2014 Feb , 29 (313-24).

110

Zhao LM et al. Advanced glycation end products impair K(Ca)3.1- and K(Ca)2.3-mediated vasodilatation via oxidative stress in rat mesenteric arteries.
Pflugers Arch., 2014 Feb , 466 (307-17).

111

Shao Z et al. Intermediate-conductance calcium-activated potassium channel KCa3.1 and chloride channel modulate chemokine ligand (CCL19/CCL21)-induced migration of dendritic cells.
Transl Res, 2014 Dec 20 , ().

112

Elíes J et al. Hydrogen sulfide inhibits Cav3.2 T-type Ca2+ channels.
FASEB J., 2014 Dec , 28 (5376-87).

113

Lin H et al. Ca2+ -activated K+ channel-3.1 blocker TRAM-34 alleviates murine allergic rhinitis.
Int. Immunopharmacol., 2014 Dec , 23 (642-8).

114

Svenningsen P et al. T-type Ca(2+) channels facilitate NO-formation, vasodilatation and NO-mediated modulation of blood pressure.
Pflugers Arch., 2014 Dec , 466 (2205-14).

115

Thuesen AD et al. Differential effect of T-type voltage-gated Ca2+ channel disruption on renal plasma flow and glomerular filtration rate in vivo.
Am. J. Physiol. Renal Physiol., 2014 Aug 15 , 307 (F445-52).

116

Dufour MA et al. Somatodendritic ion channel expression in substantia nigra pars compacta dopaminergic neurons across postnatal development.
J. Neurosci. Res., 2014 Aug , 92 (981-99).

117

Zheng H et al. Expression and function of a T-type Ca2+ conductance in interstitial cells of Cajal of the murine small intestine.
Am. J. Physiol., Cell Physiol., 2014 Apr 1 , 306 (C705-13).

118

Lieb A et al. C-terminal modulatory domain controls coupling of voltage-sensing to pore opening in Cav1.3 L-type Ca(2+) channels.
Biophys. J., 2014 Apr 1 , 106 (1467-75).

119

Grössinger EM et al. Targeting proliferation of chronic lymphocytic leukemia (CLL) cells through KCa3.1 blockade.
Leukemia, 2014 Apr , 28 (954-8).

120

Carbone E et al. T-type channel-mediated neurotransmitter release.
Pflugers Arch., 2014 Apr , 466 (677-87).

121

Mesirca P et al. T-type channels in the sino-atrial and atrioventricular pacemaker mechanism.
Pflugers Arch., 2014 Apr , 466 (791-9).

122

Kuo IY et al. Role of T-type channels in vasomotor function: team player or chameleon?
Pflugers Arch., 2014 Apr , 466 (767-79).

123

Chemin J et al. Modulation of T-type calcium channels by bioactive lipids.
Pflugers Arch., 2014 Apr , 466 (689-700).

124

Shuba YM Models of calcium permeation through T-type channels.
Pflugers Arch., 2014 Apr , 466 (635-44).

125

Sivagangabalan G et al. Regional ion channel gene expression heterogeneity and ventricular fibrillation dynamics in human hearts.
PLoS ONE, 2014 , 9 (e82179).

126

Gangarossa G et al. T-type calcium channel Cav3.2 deficient mice show elevated anxiety, impaired memory and reduced sensitivity to psychostimulants.
Front Behav Neurosci, 2014 , 8 (92).

127

Bertuccio CA et al. Anterograde trafficking of KCa3.1 in polarized epithelia is Rab1- and Rab8-dependent and recycling endosome-independent.
PLoS ONE, 2014 , 9 (e92013).

128

Roach KM et al. Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent.
Respir. Res., 2014 , 15 (155).

129

Ferreira R et al. IL-4 type 1 receptor signaling up-regulates KCNN4 expression, and increases the KCa3.1 current and its contribution to migration of alternative-activated microglia.
Front Cell Neurosci, 2014 , 8 (183).

130

Bladen C et al. Block of T-type calcium channels by protoxins I and II.
Mol Brain, 2014 , 7 (36).

131

Wandall-Frostholm C et al. Pulmonary hypertension in wild type mice and animals with genetic deficit in KCa2.3 and KCa3.1 channels.
PLoS ONE, 2014 , 9 (e97687).

132

Fu RG et al. Inhibition of the K+ channel K(Ca)3.1 reduces TGF-β1-induced premature senescence, myofibroblast phenotype transition and proliferation of mesangial cells.
PLoS ONE, 2014 , 9 (e87410).

133

Tevoufouet EE et al. Cardiac functions of voltage-gated Ca(2+) channels: role of the pharmacoresistant type (E-/R-Type) in cardiac modulation and putative implication in sudden unexpected death in epilepsy (SUDEP).
Rev. Physiol. Biochem. Pharmacol., 2014 , 167 (115-39).

134

Huang C et al. High glucose induces CCL20 in proximal tubular cells via activation of the KCa3.1 channel.
PLoS ONE, 2014 , 9 (e95173).

135

Simma N et al. NMDA-receptor antagonists block B-cell function but foster IL-10 production in BCR/CD40-activated B cells.
Cell Commun. Signal, 2014 , 12 (75).

136

Canto-Bustos M et al. Functional expression of T-type Ca2+ channels in spinal motoneurons of the adult turtle.
PLoS ONE, 2014 , 9 (e108187).

137

Jenkins DP et al. Development of a QPatch automated electrophysiology assay for identifying KCa3.1 inhibitors and activators.
Assay Drug Dev Technol, 2013 Nov-Dec , 11 (551-60).

138

Hui K et al. Efficient experimental design and analysis of real-time PCR assays.
Channels (Austin), 2013 May-Jun , 7 (160-70).

139

Chachi L et al. Functional KCa3.1 Channels Regulate Steroid Insensitivity in Bronchial Smooth Muscle Cells.
J. Immunol., 2013 Sep 1 , 191 (2624-36).

140

Elies J et al. OP20 Inhibition of recombinant T-type Ca(2+) channels by hydrogen sulfide.
Nitric Oxide, 2013 Sep 1 , 31 Suppl 2 (S27-8).

141

Radtke J et al. Activation of KCa3.1 by SKA-31 induces arteriolar dilatation and lowers blood pressure in normo- and hypertensive connexin40-deficient mice.
Br. J. Pharmacol., 2013 Sep , 170 (293-303).

142

Puthussery T et al. NaV1.1 channels in axon initial segments of bipolar cells augment input to magnocellular visual pathways in the primate retina.
J. Neurosci., 2013 Oct 9 , 33 (16045-59).

143

Senadheera S et al. Enhanced contractility in pregnancy is associated with augmented TRPC3, L-type, and T-type voltage-dependent calcium channel function in rat uterine radial artery.
Am. J. Physiol. Regul. Integr. Comp. Physiol., 2013 Oct 15 , 305 (R917-26).

144

Chen R et al. Molecular dynamics simulations of scorpion toxin recognition by the Ca(2+)-activated potassium channel KCa3.1.
Biophys. J., 2013 Oct 15 , 105 (1829-37).

145

Stoneking CJ et al. Mg(2+) modulation of the single-channel properties of KCa3.1 in human erythroleukemia cells.
Pflugers Arch., 2013 Nov 6 , ().

146

Bayazitov IT et al. Forward suppression in the auditory cortex is caused by the Ca(v)3.1 calcium channel-mediated switch from bursting to tonic firing at thalamocortical projections.
J. Neurosci., 2013 Nov 27 , 33 (18940-50).

147

Seo H et al. Effects of eugenol on T-type Ca2+ channel isoforms.
J. Pharmacol. Exp. Ther., 2013 Nov , 347 (310-7).

148

Yu ZH et al. Up-regulation of KCa3.1 promotes human airway smooth muscle cell phenotypic modulation.
Pharmacol. Res., 2013 Nov , 77 (30-8).

149

Bi D et al. The intermediate conductance calcium-activated potassium channel KCa3.1 regulates vascular smooth muscle cell proliferation via controlling calcium-dependent signaling.
J. Biol. Chem., 2013 May 31 , 288 (15843-53).

150

Gouriou Y et al. Mitochondrial Ca2+ uptake from plasma membrane Cav3.2 protein channels contributes to ischemic toxicity in PC12 cells.
J. Biol. Chem., 2013 May 3 , 288 (12459-68).

151

Leanza L et al. Correlation between potassium channel expression and sensitivity to drug-induced cell death in tumor cell lines.
Curr. Pharm. Des., 2013 May 16 , ().

152

Turner KL et al. KCa3.1 Modulates Neuroblast Migration Along the Rostral Migratory Stream (RMS) In Vivo.
Cereb. Cortex, 2013 May 15 , ().

153

Stoneking CJ et al. Voltage dependence of the Ca(2+)-activated K(+) channel K(Ca)3.1 in human erythroleukemia cells.
Am. J. Physiol., Cell Physiol., 2013 May 1 , 304 (C858-72).

154

Yang H et al. Blockade of the intermediate-conductance Ca(2+)-activated K+ channel inhibits the angiogenesis induced by epidermal growth factor in the treatment of corneal alkali burn.
Exp. Eye Res., 2013 May , 110 (76-87).

155

Nosal OV et al. Complex modulation of Ca(v)3.1 T-type calcium channel by nickel.
Cell. Mol. Life Sci., 2013 May , 70 (1653-61).

156

Liu BS et al. Microglial SK3 and SK4 currents and activation state are modulated by the neuroprotective drug, riluzole.
J Neuroimmune Pharmacol, 2013 Mar , 8 (227-37).

157

Fagerberg SK et al. P2X receptor-dependent erythrocyte damage by α-hemolysin from Escherichia coli triggers phagocytosis by THP-1 cells.
Toxins (Basel), 2013 Mar , 5 (472-87).

158

Su XL et al. Role of KCa3.1 channels in proliferation and migration of vascular smooth muscle cells by diabetic rat serum.
Chin J Physiol, 2013 Jun 30 , 56 (155-62).

159

Takai J et al. Laminar shear stress upregulates endothelial Ca2+-activated K+ channels KCa2.3 and KCa3.1 via a Ca2+/calmodulin-dependent protein kinase kinase/Akt/p300 cascade.
Am. J. Physiol. Heart Circ. Physiol., 2013 Jun 21 , ().

160

Barodka V et al. Nitroprusside inhibits calcium-induced impairment of red blood cell deformability.
Transfusion, 2013 Jun 19 , ().

161

Park WS et al. Functional expression of smooth muscle-specific ion channels in TGF-β1-treated human adipose-derived mesenchymal stem cells.
Am. J. Physiol., Cell Physiol., 2013 Jun 12 , ().

162

Howitt L et al. Chronic deficit in nitric oxide elicits oxidative stress and augments T-type calcium-channel contribution to vascular tone of rodent arteries and arterioles.
Cardiovasc. Res., 2013 Jun 1 , 98 (449-57).

163

Choi S et al. Contradictory Effects of Superoxide and Hydrogen Peroxide on KCa3.1 in Human Endothelial Cells.
Korean J. Physiol. Pharmacol., 2013 Jun , 17 (181-7).

164

Yu ZH et al. Targeted inhibition of KCa3.1 channel attenuates airway inflammation and remodeling in allergic asthma.
Am. J. Respir. Cell Mol. Biol., 2013 Jun , 48 (685-93).

165

Sah R et al. Ion channel-kinase TRPM7 is required for maintaining cardiac automaticity.
Proc. Natl. Acad. Sci. U.S.A., 2013 Jul 22 , ().

166

Harraz OF et al. Protein kinase A regulation of T-type Ca2+ channels in rat cerebral arterial smooth muscle.
J. Cell. Sci., 2013 Jul 1 , 126 (2944-54).

167

Zhang Y et al. Modulation of low-voltage-activated T-type Ca²⁺ channels.
Biochim. Biophys. Acta, 2013 Jul , 1828 (1550-9).

168

Morales P et al. Contribution of the KCa3.1 channel-calmodulin interactions to the regulation of the KCa3.1 gating process.
J. Gen. Physiol., 2013 Jul , 142 (37-60).

169

Hua X et al. The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.
Transplantation, 2013 Jan 27 , 95 (285-92).

170

Cuddapah VA et al. Bradykinin-induced chemotaxis of human gliomas requires the activation of KCa3.1 and ClC-3.
J. Neurosci., 2013 Jan 23 , 33 (1427-40).

171

Abd El-Rahman RR et al. Identification of L- and T-type Ca2+ channels in rat cerebral arteries: role in myogenic tone development.
Am. J. Physiol. Heart Circ. Physiol., 2013 Jan 1 , 304 (H58-71).

172

Zhao LM et al. KCa3.1 channels mediate the increase of cell migration and proliferation by advanced glycation endproducts in cultured rat vascular smooth muscle cells.
Lab. Invest., 2013 Feb , 93 (159-67).

173

Wulff H et al. Endothelial small-conductance and intermediate-conductance KCa channels: an update on their pharmacology and usefulness as cardiovascular targets.
J. Cardiovasc. Pharmacol., 2013 Feb , 61 (102-12).

174

Kahlfuß S et al. Immunosuppression by NMDA-Receptor Antagonists is Mediated Through Inhibition of Kv1.3 and KCa3.1 Channels in T cells.
Mol. Cell. Biol., 2013 Dec 16 , ().

175

Chimote AA et al. Selective Inhibition of KCa3.1 Channels Mediates Adenosine Regulation of the Motility of Human T Cells.
J. Immunol., 2013 Dec 15 , 191 (6273-80).

176

Jang SJ et al. In vitro cytotoxicity on human ovarian cancer cells by T-type calcium channel blockers.
Bioorg. Med. Chem. Lett., 2013 Dec 15 , 23 (6656-62).

177

Lee J et al. Sleep spindles are generated in the absence of T-type calcium channel-mediated low-threshold burst firing of thalamocortical neurons.
Proc. Natl. Acad. Sci. U.S.A., 2013 Dec 10 , 110 (20266-71).

178

Ly R et al. T-type channel blockade impairs long-term potentiation at the parallel fiber-Purkinje cell synapse and cerebellar learning.
Proc. Natl. Acad. Sci. U.S.A., 2013 Dec 10 , 110 (20302-7).

179

Sukumaran SV et al. TRPV4 channel activation leads to endothelium-dependent relaxation mediated by nitric oxide and endothelium-derived hyperpolarizing factor in rat pulmonary artery.
Pharmacol. Res., 2013 Dec , 78 (18-27).

180

Kelly MJ et al. Pacemaking Kisspeptin Neurons.
Exp. Physiol., 2013 Aug 30 , ().

181

Le Quang K et al. T-type calcium current contributes to escape automaticity and governs the occurrence of lethal arrhythmias after atrioventricular block in mice.
Circ Arrhythm Electrophysiol, 2013 Aug , 6 (799-808).

182

Boycott HE et al. Carbon monoxide inhibition of Cav3.2 T-type Ca2+ channels reveals tonic modulation by thioredoxin.
FASEB J., 2013 Aug , 27 (3395-407).

183

Huang C et al. Blockade of KCa3.1 ameliorates renal fibrosis through the TGF-β1/Smad pathway in diabetic mice.
Diabetes, 2013 Aug , 62 (2923-34).

184

Shan HQ et al. Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C.
Alcohol. Clin. Exp. Res., 2013 Aug , 37 (1333-42).

185

Salem KA et al. Effects of exercise training on excitation-contraction coupling and related mRNA expression in hearts of Goto-Kakizaki type 2 diabetic rats.
Mol. Cell. Biochem., 2013 Aug , 380 (83-96).

186

Weisbrod D et al. SK4 Ca2+ activated K+ channel is a critical player in cardiac pacemaker derived from human embryonic stem cells.
Proc. Natl. Acad. Sci. U.S.A., 2013 Apr 30 , 110 (E1685-94).

187

Wang J et al. Purinergic regulation of CFTR and Ca(2+)-activated Cl(-) channels and K(+) channels in human pancreatic duct epithelium.
Am. J. Physiol., Cell Physiol., 2013 Apr 1 , 304 (C673-84).

188

Choi S et al. NADPH oxidase 2-derived superoxide downregulates endothelial KCa3.1 in preeclampsia.
Free Radic. Biol. Med., 2013 Apr , 57 (10-21).

189

Jørgensen S et al. A high-throughput screening campaign for detection of ca(2+)-activated k(+) channel activators and inhibitors using a fluorometric imaging plate reader-based tl(+)-influx assay.
Assay Drug Dev Technol, 2013 Apr , 11 (163-72).

190

Hejl JL et al. P2X receptor stimulation amplifies complement-induced haemolysis.
Pflugers Arch., 2013 Apr , 465 (529-41).

191

D'Alessandro G et al. KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo.
Cell Death Dis, 2013 , 4 (e773).

192

Oliván-Viguera A et al. Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3.
PLoS ONE, 2013 , 8 (e58614).

193

Roach KM et al. The K(+) Channel KCa3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis.
PLoS ONE, 2013 , 8 (e85244).

194

Atkinson AJ et al. Functional, anatomical, and molecular investigation of the cardiac conduction system and arrhythmogenic atrioventricular ring tissue in the rat heart.
J Am Heart Assoc, 2013 , 2 (e000246).

195

Ferreira R et al. Selective activation of KCa3.1 and CRAC channels by P2Y2 receptors promotes Ca(2+) signaling, store refilling and migration of rat microglial cells.
PLoS ONE, 2013 , 8 (e62345).

196

Sousa SR et al. Expression and pharmacology of endogenous Cav channels in SH-SY5Y human neuroblastoma cells.
PLoS ONE, 2013 , 8 (e59293).

197

Strandberg LS et al. Congenital heart block maternal sera autoantibodies target an extracellular epitope on the α1G T-type calcium channel in human fetal hearts.
PLoS ONE, 2013 , 8 (e72668).

198

Sekiguchi F et al. T-type calcium channels: functional regulation and implication in pain signaling.
J. Pharmacol. Sci., 2013 , 122 (244-50).

199

Chen YJ et al. The Ca²⁺-activated K⁺ channel KCa3.1 as a potential new target for the prevention of allograft vasculopathy.
PLoS ONE, 2013 , 8 (e81006).

200

Koshy S et al. Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes.
PLoS ONE, 2013 , 8 (e76740).

201

Kobrinsky E et al. Selective fluorophore-assisted light inactivation of voltage-gated calcium channels.
Channels (Austin), 2012 May-Jun , 6 (154-6).

202

Isope P et al. Contributions of T-type voltage-gated calcium channels to postsynaptic calcium signaling within Purkinje neurons.
Cerebellum, 2012 Sep , 11 (651-65).

203

Lopez-Charcas O et al. Block of human CaV3 channels by the diuretic amiloride.
Mol. Pharmacol., 2012 Oct , 82 (658-67).

204

Balut CM et al. Trafficking of intermediate (KCa3.1) and small (KCa2.x) conductance, Ca(2+)-activated K(+) channels: a novel target for medicinal chemistry efforts?
ChemMedChem, 2012 Oct , 7 (1741-55).

205

Francois A et al. State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects.
Pain, 2012 Nov 5 , ().

206

Preiksaitiene E et al. A novel de novo 1.8 Mb microdeletion of 17q21.33 associated with intellectual disability and dysmorphic features.
Eur J Med Genet, 2012 Nov , 55 (656-9).

207

Toledo A et al. Insulin-mediated upregulation of T-type Ca2+ currents in GH3 cells is mediated by increased endosomal recycling and incorporation of surface membrane Cav3.1 channels.
Cell Calcium, 2012 Nov , 52 (377-87).

208

Chevalier M et al. Dehydroepiandrosterone (DHEA) inhibits voltage-gated T-type calcium channels.
, 2012 Mar 3 , ().

209

Bao XX et al. [Impact of calcium channel antagonists for estrogen action on the endometrial carcinoma HEC-1A cells].
Zhonghua Fu Chan Ke Za Zhi, 2012 Mar , 47 (212-7).

210

Balderas E et al. Niflumic acid blocks native and recombinant T-type channels.
J. Cell. Physiol., 2012 Jun , 227 (2542-55).

211

Wang Y et al. [Influence of acupuncture on expression of T-type calcium channel protein in airway smooth muscle cell in airway remodeling rats with asthma].
Zhongguo Zhen Jiu, 2012 Jun , 32 (534-40).

212

Hawkins NA et al. Confirmation of an epilepsy modifier locus on mouse chromosome 11 and candidate gene analysis by RNA-Seq.
Genes Brain Behav., 2012 Jun , 11 (452-60).

213

Mor M et al. ZnT-1 enhances the activity and surface expression of T-type calcium channels through activation of Ras-ERK signaling.
Am. J. Physiol., Cell Physiol., 2012 Jul 15 , 303 (C192-203).

214

Li CX et al. [Distribution diversity of integrins and calcium channels on major human and mouse host cells of Leptospira species].
Zhejiang Da Xue Xue Bao Yi Xue Ban, 2012 Jul , 41 (410-7).

215

Ohkubo T et al. T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells.
Int. J. Oncol., 2012 Jul , 41 (267-75).

216

Zhang Y et al. Inhibition of T-type Ca(2+) channels by endostatin attenuates human glioblastoma cell proliferation and migration.
, 2012 Jan 10 , ().

217

Damkjaer M et al. Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs.
Br. J. Pharmacol., 2012 Jan , 165 (223-34).

218

Zhang J et al. Regulation of Cell Proliferation of Human Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells via Ether a go-go 1 (hEAG1) Potassium Channel.
, 2012 Feb 22 , ().

219

Engbers JD et al. Intermediate conductance calcium-activated potassium channels modulate summation of parallel fiber input in cerebellar Purkinje cells.
Proc. Natl. Acad. Sci. U.S.A., 2012 Feb 14 , 109 (2601-6).

220

Al-Hazza A et al. Potential role of reduced basolateral potassium (IKCa3.1) channel expression in the pathogenesis of diarrhoea in ulcerative colitis.
J. Pathol., 2012 Feb , 226 (463-70).

221

Xu R et al. Kv1.3 channels as a potential target for immunomodulation of CD4+ CD28null T cells in patients with acute coronary syndrome.
Clin. Immunol., 2012 Feb , 142 (209-17).

222

Yarotskyy V et al. Roscovitine inhibits CaV3.1 (T-type) channels by preferentially affecting closed-state inactivation.
J. Pharmacol. Exp. Ther., 2012 Feb , 340 (463-72).

223

Tzeng BH et al. The Ca(v)3.1 T-type calcium channel is required for neointimal formation in response to vascular injury in mice.
Cardiovasc. Res., 2012 Dec 1 , 96 (533-42).

224

Lopin KV et al. Fe²⁺ block and permeation of CaV3.1 (α1G) T-type calcium channels: candidate mechanism for non-transferrin-mediated Fe²⁺ influx.
Mol. Pharmacol., 2012 Dec , 82 (1194-204).

225

Lopin KV et al. Cd²⁺ block and permeation of CaV3.1 (α1G) T-type calcium channels: candidate mechanism for Cd²⁺ influx.
Mol. Pharmacol., 2012 Dec , 82 (1183-93).

226

Zhao LM et al. Advanced glycation end products promote proliferation of cardiac fibroblasts by upregulation of KCa3.1 channels.
Pflugers Arch., 2012 Dec , 464 (613-21).

227

Srivastava S et al. Phosphatidylinositol-3-kinase C2β and TRIM27 function to positively and negatively regulate IgE receptor activation of mast cells.
Mol. Cell. Biol., 2012 Aug , 32 (3132-9).

228

Kolaj M et al. Midline thalamic paraventricular nucleus neurons display diurnal variation in resting membrane potentials, conductances, and firing patterns in vitro.
J. Neurophysiol., 2012 Apr , 107 (1835-44).

229

Siwek M et al. Voltage-gated ca(2+) channel mediated ca(2+) influx in epileptogenesis.
Adv. Exp. Med. Biol., 2012 , 740 (1219-47).

230

Yang XF et al. The antibody targeting the e314 Peptide of human kv1.3 pore region serves as a novel, potent and specific channel blocker.
PLoS ONE, 2012 , 7 (e36379).

231

Bodendiek SB et al. Triarylmethanes, a new class of cx50 inhibitors.
Front Pharmacol, 2012 , 3 (106).

232

Catacuzzeno L et al. Expression and Role of the Intermediate-Conductance Calcium-Activated Potassium Channel KCa3.1 in Glioblastoma.
J Signal Transduct, 2012 , 2012 (421564).

233

Takahashi K et al. Hypoxic stress induces transient receptor potential melastatin 2 (TRPM2) channel expression in adult rat cardiac fibroblasts.
J. Pharmacol. Sci., 2012 , 118 (186-97).

234

Wisniewska MB et al. Novel β-catenin target genes identified in thalamic neurons encode modulators of neuronal excitability.
BMC Genomics, 2012 , 13 (635).

235

Kuras Z et al. KCa3.1 and TRPM7 channels at the uropod regulate migration of activated human T cells.
PLoS ONE, 2012 , 7 (e43859).

236

Forsythe P et al. Systemic effects of ingested Lactobacillus rhamnosus: inhibition of mast cell membrane potassium (IKCa) current and degranulation.
PLoS ONE, 2012 , 7 (e41234).

237

Senatore A et al. Gene transcription and splicing of T-type channels are evolutionarily-conserved strategies for regulating channel expression and gating.
PLoS ONE, 2012 , 7 (e37409).

238

Ruggieri P et al. The inhibition of KCa3.1 channels activity reduces cell motility in glioblastoma derived cancer stem cells.
PLoS ONE, 2012 , 7 (e47825).

239

Lambertsen KL et al. Genetic KCa3.1-deficiency produces locomotor hyperactivity and alterations in cerebral monoamine levels.
PLoS ONE, 2012 , 7 (e47744).

240

Li Y et al. β-Adrenergic stimulation increases Cav3.1 activity in cardiac myocytes through protein kinase A.
PLoS ONE, 2012 , 7 (e39965).

241

Tang AH et al. Nerve terminal nicotinic acetylcholine receptors initiate quantal GABA release from perisomatic interneurons by activating axonal T-type (Cav3) Ca²⁺ channels and Ca²⁺ release from stores.
J. Neurosci., 2011 Sep 21 , 31 (13546-61).

242

Fang K et al. Mechanism of auxiliary β-subunit-mediated membrane targeting of L-type (Ca(V)1.2) channels.
J. Physiol. (Lond.), 2011 Sep 15 , 589 (4437-55).

243

Hasenau AL et al. Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small- and intermediate-conductance Ca2+ -activated K+ -channels.
Acta Physiol (Oxf), 2011 Sep , 203 (117-26).

244

Howarth FC et al. Contractility of ventricular myocytes is well preserved despite altered mechanisms of Ca(2+) transport and a changing pattern of mRNA in aged type 2 Zucker diabetic fatty rat heart.
, 2011 Oct 19 , ().

245

Bouhy D et al. Inhibition of the Ca²⁺-dependent K⁺ channel, KCNN4/KCa3.1, improves tissue protection and locomotor recovery after spinal cord injury.
J. Neurosci., 2011 Nov 9 , 31 (16298-308).

246

Shao Z et al. Calcium-activated potassium channel KCa3.1 in lung dendritic cell migration.
Am. J. Respir. Cell Mol. Biol., 2011 Nov , 45 (962-8).

247

Balut CM et al. Role of ubiquitylation and USP8-dependent deubiquitylation in the endocytosis and lysosomal targeting of plasma membrane KCa3.1.
FASEB J., 2011 Nov , 25 (3938-48).

248

Ku WH et al. Multiple T-type Ca2+ current subtypes in electrophysiologically characterized hamster dorsal horn neurons: possible role in spinal sensory integration.
J. Neurophysiol., 2011 Nov , 106 (2486-98).

249

Matsunami M et al. Chelating luminal zinc mimics hydrogen sulfide-evoked colonic pain in mice: possible involvement of T-type calcium channels.
Neuroscience, 2011 May 5 , 181 (257-64).

250

Palmer ML et al. KCa3.1 channels facilitate K+ secretion or ENaC-dependent Na+ absorption depending on apical or basolateral P2Y receptor stimulation.
, 2011 May 23 , ().

251

Kim J et al. Thalamic T-type Ca²+ channels mediate frontal lobe dysfunctions caused by a hypoxia-like damage in the prefrontal cortex.
J. Neurosci., 2011 Mar 16 , 31 (4063-73).

252

Pluteanu F et al. Regulation and function of Cav3.1 T-type calcium channels in IGF-I-stimulated pulmonary artery smooth muscle cells.
Am. J. Physiol., Cell Physiol., 2011 Mar , 300 (C517-25).

253

Choi KH et al. Pharmacological studies of Cav3.1 T-type calcium channels using automated patch-clamp techniques.
Gen. Physiol. Biophys., 2011 Mar , 30 (100-5).

254

Howarth FC et al. Changing pattern of gene expression is associated with ventricular myocyte dysfunction and altered mechanisms of Ca2+ signalling in young type 2 Zucker diabetic fatty rat heart.
Exp. Physiol., 2011 Mar , 96 (325-37).

255

Ono S et al. Characterization of voltage-dependent calcium channel blocking peptides from the venom of the tarantula Grammostola rosea.
, 2011 Jun 28 , ().

256

Chang KY et al. Lack of CaV3.1 channels causes severe motor coordination defects and an age-dependent cerebellar atrophy in a genetic model of essential tremor.
Biochem. Biophys. Res. Commun., 2011 Jun 24 , 410 (19-23).

257

Welsh JP et al. Bidirectional plasticity in the primate inferior olive induced by chronic ethanol intoxication and sustained abstinence.
Proc. Natl. Acad. Sci. U.S.A., 2011 Jun 21 , 108 (10314-9).

258

Beckman-Sundh U et al. A screening method for phosphohistidine phosphatase 1 activity.
, 2011 Jun 17 , ().

259

Li W et al. Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation.
Cancer Invest., 2011 Jun , 29 (339-46).

260

Zhang XH et al. Functional ion channels and cell proliferation in 3T3-L1 preadipocytes.
, 2011 Jul 5 , ().

261

Marger L et al. Functional roles of CaV 1.3, CaV 3.1 and HCN channels in automaticity of mouse atrioventricular cells: insights into the atrioventricular pacemaker mechanism.
, 2011 Jul 1 , 5 ().

262

Greener ID et al. Molecular architecture of the human specialised atrioventricular conduction axis.
, 2011 Jan 21 , ().

263

Hazra R et al. A transcriptomic analysis of type I-III neurons in the bed nucleus of the stria terminalis.
, 2011 Feb 7 , ().

264

Maezawa I et al. Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity.
J. Biol. Chem., 2011 Feb 4 , 286 (3693-706).

265

Poulsen CB et al. T-type voltage-gated calcium channels regulate the tone of mouse efferent arterioles.
Kidney Int., 2011 Feb , 79 (443-51).

266

Yalçın O Genes and molecular mechanisms involved in the epileptogenesis of idiopathic absence epilepsies.
, 2011 Dec 27 , ().

267

Liu G et al. [Regulation of T-type Ca(2+) channel in lysophosphatidylcholine-stimulated cardiomyocytes].
Beijing Da Xue Xue Bao, 2011 Dec 18 , 43 (804-8).

268

Cai X et al. Tripartite motif containing protein 27 negatively regulates CD4 T cells by ubiquitinating and inhibiting the class II PI3K-C2β.
Proc. Natl. Acad. Sci. U.S.A., 2011 Dec 13 , 108 (20072-7).

269

Chen YJ et al. The KCa3.1 blocker TRAM-34 reduces infarction and neurological deficit in a rat model of ischemia/reperfusion stroke.
J. Cereb. Blood Flow Metab., 2011 Dec , 31 (2363-74).

270

Lacinová L T-type calcium channel blockers - new and notable.
Gen. Physiol. Biophys., 2011 Dec , 30 (403-9).

271

Astori S et al. The Ca(V)3.3 calcium channel is the major sleep spindle pacemaker in thalamus.
Proc. Natl. Acad. Sci. U.S.A., 2011 Aug 16 , 108 (13823-8).

272

Chi V et al. Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases.
, 2011 Aug 12 , ().

273

Okubo K et al. Inhibition of T-type calcium channels and hydrogen sulfide-forming enzyme reverses paclitaxel-evoked neuropathic hyperalgesia in rats.
Neuroscience, 2011 Aug 11 , 188 (148-56).

274

Linnertz R et al. Activation of voltage-gated Na⁺ and Ca²⁺ channels is required for glutamate release from retinal glial cells implicated in cell volume regulation.
Neuroscience, 2011 Aug 11 , 188 (23-34).

275

Le Quang K et al. Role of T-type calcium channel subunits in post-myocardial infarction remodelling probed with genetically engineered mice.
Cardiovasc. Res., 2011 Aug 1 , 91 (420-8).

276

Ohya S et al. Intermediate-conductance Ca2+-activated K+ channel, KCa3.1, as a novel therapeutic target for benign prostatic hyperplasia.
J. Pharmacol. Exp. Ther., 2011 Aug , 338 (528-36).

277

Lei D et al. Anti-epileptic drugs delay age-related loss of spiral ganglion neurons via T-type calcium channel.
Hear. Res., 2011 Aug , 278 (106-12).

278

Chen WC et al. Complex distribution patterns of voltage-gated calcium channel α-subunits in the spiral ganglion.
Hear. Res., 2011 Aug , 278 (52-68).

279

Ferron L et al. T-type Ca²+ signalling regulates aldosterone-induced CREB activation and cell death through PP2A activation in neonatal cardiomyocytes.
Cardiovasc. Res., 2011 Apr 1 , 90 (105-12).

280

Waschk DE et al. Dual-color quantum dot detection of a heterotetrameric potassium channel (hKCa3.1).
Am. J. Physiol., Cell Physiol., 2011 Apr , 300 (C843-9).

281

Cieśla J et al. Phosphorylation of basic amino acid residues in proteins: important but easily missed.
Acta Biochim. Pol., 2011 , 58 (137-48).

282

Wang Q et al. Effects of raloxifene on voltage-dependent T-type Ca2+ channels in mouse spermatogenic cells.
Pharmacology, 2011 , 87 (70-80).

283

Rotte A et al. Ca2+ activated K+ channel Kca3.1 as a determinant of gastric acid secretion.
Cell. Physiol. Biochem., 2011 , 27 (597-604).

284

Schernhammer ES et al. B vitamins, methionine and alcohol intake and risk of colon cancer in relation to BRAF mutation and CpG island methylator phenotype (CIMP).
PLoS ONE, 2011 , 6 (e21102).

285

David LS et al. Splice-variant changes of the Ca(V)3.2 T-type calcium channel mediate voltage-dependent facilitation and associate with cardiac hypertrophy and development.
Channels (Austin), 2010 Sep-Oct , 4 (375-89).

286

Cribbs L T-type calcium channel expression and function in the diseased heart.
Channels (Austin), 2010 Nov-Dec , 4 (447-52).

287

Cain SM et al. Contributions of T-type calcium channel isoforms to neuronal firing.
Channels (Austin), 2010 Nov-Dec , 4 (475-82).

288

Perez-Reyes E Characterization of the gating brake in the I-II loop of CaV3 T-type calcium channels.
Channels (Austin), 2010 Nov-Dec , 4 (453-8).

289

Anderson D et al. Regulation of the KV4.2 complex by CaV3.1 calcium channels.
Channels (Austin), 2010 May-Jun , 4 (163-7).

290

Sassi N et al. An investigation of the occurrence and properties of the mitochondrial intermediate-conductance Ca2+-activated K+ channel mtKCa3.1.
Biochim. Biophys. Acta, 2010 Jun-Jul , 1797 (1260-7).

291

Edgerton GB et al. Inhibition of the activation pathway of the T-type calcium channel Ca(V)3.1 by ProTxII.
Toxicon, 2010 Sep 15 , 56 (624-36).

292

Nikitina E et al. Alteration in voltage-dependent calcium channels in dog basilar artery after subarachnoid hemorrhage. Laboratory investigation.
J. Neurosurg., 2010 Oct , 113 (870-80).

293

Haren N et al. Intermediate conductance Ca2+ activated K+ channels are expressed and functional in breast adenocarcinomas: correlation with tumour grade and metastasis status.
Histol. Histopathol., 2010 Oct , 25 (1247-55).

294

Bailey MA et al. Characterization of the PCMBS-dependent modification of KCa3.1 channel gating.
J. Gen. Physiol., 2010 Oct , 136 (367-87).

295

Waleh N et al. Patterns of gene expression in the ductus arteriosus are related to environmental and genetic risk factors for persistent ductus patency.
Pediatr. Res., 2010 Oct , 68 (292-7).

296

Strom SP et al. High-density SNP association study of the 17q21 chromosomal region linked to autism identifies CACNA1G as a novel candidate gene.
Mol. Psychiatry, 2010 Oct , 15 (996-1005).

297

Markandeya YS et al. Caveolin-3 regulates the protein kinase A modulation of CaV3.2 ({alpha}1H) T-type Ca2+ channels.
, 2010 Nov 17 , ().

298

Balut CM et al. ESCRT-dependent targeting of plasma membrane localized KCa3.1 to the lysosomes.
Am. J. Physiol., Cell Physiol., 2010 Nov , 299 (C1015-27).

299

Kraus RL et al. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
J. Pharmacol. Exp. Ther., 2010 Nov , 335 (409-17).

300

Karmazinova M et al. Cysteines in the loop between IS5 and the pore helix of Ca(V)3.1 are essential for channel gating.
Pflugers Arch., 2010 Nov , 460 (1015-28).

301

Schmidt J et al. Migration-associated secretion of melanoma inhibitory activity at the cell rear is supported by KCa3.1 potassium channels.
Cell Res., 2010 Nov , 20 (1224-38).

302

Handforth A et al. T-type calcium channel antagonists suppress tremor in two mouse models of essential tremor.
Neuropharmacology, 2010 Nov , 59 (380-7).

303

Ou Y et al. Expression of key ion channels in the rat cardiac conduction system by laser capture microdissection and qPCR.
, 2010 May 28 , ().

304

Han DY et al. K+ channel openers restore verapamil-inhibited fluid resolution and transepithelial ion transport systems.
, 2010 May 27 , 11 (65).

305

Strege PR et al. T-type Ca(2+) channel modulation by otilonium bromide.
Am. J. Physiol. Gastrointest. Liver Physiol., 2010 May , 298 (G706-13).

306

Köhler R et al. Endothelial dysfunction and blood pressure alterations in K+-channel transgenic mice.
Pflugers Arch., 2010 May , 459 (969-76).

307

Balut CM et al. Immunofluorescence-based assay to identify modulators of the number of plasma membrane KCa3.1 channels.
Future Med Chem, 2010 May , 2 (707-13).

308

Thévenod F Catch me if you can! Novel aspects of cadmium transport in mammalian cells.
, 2010 Mar 5 , ().

309

Rangaraju S et al. Potassium channel modulation by a toxin domain in matrix metalloprotease 23.
J. Biol. Chem., 2010 Mar 19 , 285 (9124-36).

310

Park YG et al. Ca(V)3.1 is a tremor rhythm pacemaker in the inferior olive.
Proc. Natl. Acad. Sci. U.S.A., 2010 Jun 8 , 107 (10731-6).

311

Gao Y et al. Recycling of the Ca2+-activated K+ channel, KCa2.3, is dependent upon RME-1, Rab35/EPI64C, and an N-terminal domain.
J. Biol. Chem., 2010 Jun 4 , 285 (17938-53).

312

Lopin KV et al. Evaluation of a two-site, three-barrier model for permeation in Ca(V)3.1 (alpha1G) T-type calcium channels: Ca (2+), Ba (2+), Mg (2+), and Na (+).
J. Membr. Biol., 2010 Jun , 235 (131-43).

313

Oguri A et al. Involvement of CaV3.1 T-type calcium channels in cell proliferation in mouse preadipocytes.
Am. J. Physiol., Cell Physiol., 2010 Jun , 298 (C1414-23).

314

Aromolaran KA et al. T-type current modulation by the actin-binding protein Kelch-like 1.
Am. J. Physiol., Cell Physiol., 2010 Jun , 298 (C1353-62).

315

Kuo IY et al. Dihydropyridine-insensitive calcium currents contribute to function of small cerebral arteries.
J. Cereb. Blood Flow Metab., 2010 Jun , 30 (1226-39).

316

Lee JE et al. Synthesis and biological evaluation of oxazole derivatives as T-type calcium channel blockers.
Bioorg. Med. Chem. Lett., 2010 Jul 15 , 20 (4219-22).

317

Singh A et al. The transient receptor potential channel antagonist SKF96365 is a potent blocker of low-voltage-activated T-type calcium channels.
Br. J. Pharmacol., 2010 Jul , 160 (1464-75).

318

Di L et al. Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis.
Proc. Natl. Acad. Sci. U.S.A., 2010 Jan 26 , 107 (1541-6).

319

Zheng M et al. Intracellular Ca(2+)- and PKC-dependent upregulation of T-type Ca(2+) channels in LPC-stimulated cardiomyocytes.
J. Mol. Cell. Cardiol., 2010 Jan , 48 (131-9).

320

Ono K et al. Cardiac T-type Ca(2+) channels in the heart.
J. Mol. Cell. Cardiol., 2010 Jan , 48 (65-70).

321

Köhler R et al. Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease.
Expert Opin. Ther. Targets, 2010 Feb , 14 (143-55).

322

BenMohamed F et al. Identification of functional corticosteroid response elements involved in regulation of Cacna1g expression in cardiac myocytes.
Mol. Cell. Biochem., 2010 Feb , 335 (47-51).

323

Tanaka H et al. Effects of S(+)-efonidipine on the rabbit sinus node action potential and calcium channel subunits Ca(V)1.2, Ca(V)1.3 and Ca(V)3.1.
Eur. J. Pharmacol., 2010 Dec 15 , 649 (263-7).

324

Skaper SD Ion Channels on Microglia: Therapeutic Targets for Neuroprotection.
, 2010 Dec 14 , ().

325

Di L et al. Nucleoside diphosphate kinase B knock-out mice have impaired activation of the K+ channel KCa3.1, resulting in defective T cell activation.
J. Biol. Chem., 2010 Dec 10 , 285 (38765-71).

326

Karmazinova M et al. Removal of the outermost arginine in IVS4 segment of the Ca(V)3.1 channel affects amplitude but not voltage dependence of gating current.
Gen. Physiol. Biophys., 2010 Dec , 29 (419-23).

327

Chen WK et al. Ca(v)3.2 T-type Ca2+ channel-dependent activation of ERK in paraventricular thalamus modulates acid-induced chronic muscle pain.
J. Neurosci., 2010 Aug 4 , 30 (10360-8).

328

Schicker KW et al. P2Y1 receptors mediate an activation of neuronal calcium-dependent K+ channels.
, 2010 Aug 2 , ().

329

Choi S et al. Subthreshold membrane potential oscillations in inferior olive neurons are dynamically regulated by P/Q- and T-type calcium channels: a study in mutant mice.
J. Physiol. (Lond.), 2010 Aug 15 , 588 (3031-43).

330

Souvannakitti D et al. NADPH oxidase-dependent regulation of T-type Ca2+ channels and ryanodine receptors mediate the augmented exocytosis of catecholamines from intermittent hypoxia-treated neonatal rat chromaffin cells.
J. Neurosci., 2010 Aug 11 , 30 (10763-72).

331

Pastukh V et al. Effect of hypernatremia on injury caused by energy deficiency: role of T-type Ca2+ channel.
Am. J. Physiol., Cell Physiol., 2010 Aug , 299 (C289-97).

332

Wisniewska MB et al. LEF1/beta-catenin complex regulates transcription of the Cav3.1 calcium channel gene (Cacna1g) in thalamic neurons of the adult brain.
J. Neurosci., 2010 Apr 7 , 30 (4957-69).

333

Eckle VS et al. Mechanisms of inhibition of Ca(V)3.1 T-type calcium current by aliphatic alcohols 03/25/2010.
, 2010 Apr 1 , ().

334

Vandorpe DH et al. Hypoxia activates a Ca2+-permeable cation conductance sensitive to carbon monoxide and to GsMTx-4 in human and mouse sickle erythrocytes.
PLoS ONE, 2010 , 5 (e8732).

335

Wen XJ et al. The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia.
Pharmacology, 2010 , 85 (295-300).

336

Dyrda A et al. Local membrane deformations activate Ca2+-dependent K+ and anionic currents in intact human red blood cells.
PLoS ONE, 2010 , 5 (e9447).

337

Garneau L et al. Toward the Rational Design of Constitutively Active KCa3.1 Mutant Channels.
Meth. Enzymol., 2010 , 485 (437-57).

338

Orecná M et al. Cell swelling-induced insulin secretion from INS-1E cells is inhibited by extracellular Ca2+ and is tetanus toxin resistant.
Cell. Physiol. Biochem., 2010 , 26 (197-208).

339

Mizuta E et al. Different distribution of Cav3.2 and Cav3.1 transcripts encoding T-type Ca(2+) channels in the embryonic heart of mice.
Biomed. Res., 2010 , 31 (301-5).

340

Drews G Physiological significance of SK4 channels in pancreatic β-cell oscillations.
Islets, 2009 Sep-Oct , 1 (148-50).

341

Grgic I et al. Blockade of T-lymphocyte KCa3.1 and Kv1.3 channels as novel immunosuppression strategy to prevent kidney allograft rejection.
Transplant. Proc., 2009 Jul-Aug , 41 (2601-6).

342

Srivastava S et al. The class II phosphatidylinositol 3 kinase C2beta is required for the activation of the K+ channel KCa3.1 and CD4 T-cells.
Mol. Biol. Cell, 2009 Sep , 20 (3783-91).

343

Cahalan MD et al. The functional network of ion channels in T lymphocytes.
Immunol. Rev., 2009 Sep , 231 (59-87).

344

Barbara G et al. T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids.
J. Neurosci., 2009 Oct 21 , 29 (13106-14).

345

Drígelová M et al. The dihydropyridine analogue cerebrocrast blocks both T-type and L-type calcium currents.
Can. J. Physiol. Pharmacol., 2009 Nov , 87 (923-32).

346

Lewis BB et al. Cloning and characterization of voltage-gated calcium channel alpha1 subunits in Xenopus laevis during development.
Dev. Dyn., 2009 Nov , 238 (2891-902).

347

Walsh CP et al. Labelling of the 3D structure of the cardiac L-type voltage-gated calcium channel.
Channels (Austin), 2009 Nov , 3 (387-92).

348

Chen RS et al. A small peptide inhibitor of the low voltage-activated calcium channel Cav3.1.
Mol. Pharmacol., 2009 May , 75 (1042-51).

349

De Marchi U et al. Intermediate conductance Ca2+-activated potassium channel (KCa3.1) in the inner mitochondrial membrane of human colon cancer cells.
Cell Calcium, 2009 May , 45 (509-16).

350

Harron SA et al. Volume regulation in the human airway epithelial cell line Calu-3.
Can. J. Physiol. Pharmacol., 2009 May , 87 (337-46).

351

Yeh YH et al. Funny current downregulation and sinus node dysfunction associated with atrial tachyarrhythmia: a molecular basis for tachycardia-bradycardia syndrome.
Circulation, 2009 Mar 31 , 119 (1576-85).

352

Walsh CP et al. 3D structure of CaV3.1 - comparison with the cardiac L-type voltage-gated calcium channel monomer architecture.
J. Biol. Chem., 2009 Jun 11 , ().

353

Wölfle SE et al. Prominent role of KCa3.1 in endothelium-derived hyperpolarizing factor-type dilations and conducted responses in the microcirculation in vivo.
Cardiovasc. Res., 2009 Jun 1 , 82 (476-83).

354

Grgic I et al. Disruption of the Gardos channel (KCa3.1) in mice causes subtle erythrocyte macrocytosis and progressive splenomegaly.
Pflugers Arch., 2009 Jun , 458 (291-302).

355

Grgic I et al. Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses--relevance to cardiovascular pathologies and drug discovery.
Br. J. Pharmacol., 2009 Jun , 157 (509-26).

356

Uebele VN et al. Antagonism of T-type calcium channels inhibits high-fat diet-induced weight gain in mice.
J. Clin. Invest., 2009 Jun , 119 (1659-67).

357

Bosch MA et al. 17Beta-estradiol regulation of the mRNA expression of T-type calcium channel subunits: role of estrogen receptor alpha and estrogen receptor beta.
J. Comp. Neurol., 2009 Jan 20 , 512 (347-58).

358

Garneau L et al. Hydrophobic interactions as key determinants to the KCa3.1 channel closed configuration. An analysis of KCa3.1 mutants constitutively active in zero Ca2+.
J. Biol. Chem., 2009 Jan 2 , 284 (389-403).

359

BenMohamed F et al. Regulation of T-type Cav3.1 channels expression by synthetic glucocorticoid dexamethasone in neonatal cardiac myocytes.
Mol. Cell. Biochem., 2009 Jan , 320 (173-83).

360

Jensen LJ et al. Is there a role for T-type Ca2+ channels in regulation of vasomotor tone in mesenteric arterioles?
Can. J. Physiol. Pharmacol., 2009 Jan , 87 (8-20).

361

Tharp DL et al. The intermediate-conductance Ca2+ -activated K+ channel (KCa3.1) in vascular disease.
, 2009 Jan , 7 (1-11).

362

Ernst WL et al. Genetic enhancement of thalamocortical network activity by elevating alpha 1g-mediated low-voltage-activated calcium current induces pure absence epilepsy.
J. Neurosci., 2009 Feb 11 , 29 (1615-25).

363

Tao J et al. Tyrosine kinase-independent inhibition by genistein on spermatogenic T-type calcium channels attenuates mouse sperm motility and acrosome reaction.
Cell Calcium, 2009 Feb , 45 (133-43).

364

Sankaranarayanan A et al. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.
Mol. Pharmacol., 2009 Feb , 75 (281-95).

365

Klein H et al. Inhibition of the KCa3.1 channels by AMP-activated protein kinase in human airway epithelial cells.
Am. J. Physiol., Cell Physiol., 2009 Feb , 296 (C285-95).

366

Koyama T et al. Molecular and electrical remodeling of L- and T-type Ca(2+) channels in rat right atrium with monocrotaline-induced pulmonary hypertension.
Circ. J., 2009 Feb , 73 (256-63).

367

Köhler R Single-nucleotide polymorphisms in vascular Ca(2+)-activated K (+)-channel genes and cardiovascular disease.
, 2009 Dec 31 , ().

368

Chantome A et al. KCa2.3 channel-dependent hyperpolarization increases melanoma cell motility.
Exp. Cell Res., 2009 Dec 10 , 315 (3620-30).

369

Nakayama H et al. alpha1G-dependent T-type Ca2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in mice.
J. Clin. Invest., 2009 Dec , 119 (3787-96).

370

Hildebrand ME et al. Functional coupling between mGluR1 and Cav3.1 T-type calcium channels contributes to parallel fiber-induced fast calcium signaling within Purkinje cell dendritic spines.
J. Neurosci., 2009 Aug 5 , 29 (9668-82).

371

Zhang C et al. 17Beta-estradiol regulation of T-type calcium channels in gonadotropin-releasing hormone neurons.
J. Neurosci., 2009 Aug 26 , 29 (10552-62).

372

Grgic I et al. Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels.
Proc. Natl. Acad. Sci. U.S.A., 2009 Aug 25 , 106 (14518-23).

373

Düfer M et al. Enhanced glucose tolerance by SK4 channel inhibition in pancreatic beta-cells.
Diabetes, 2009 Aug , 58 (1835-43).

374

Klumpp S et al. Reversible phosphorylation of histidine residues in proteins from vertebrates.
, 2009 , 2 (pe13).

375

Ernst WL et al. Expanded alternative splice isoform profiling of the mouse Cav3.1/alpha1G T-type calcium channel.
BMC Mol. Biol., 2009 , 10 (53).

376

Lee S et al. Molecular characterization of T-type Ca(2+) channels responsible for low threshold spikes in hypothalamic paraventricular nucleus neurons.
Neuroscience, 2008 Sep 9 , 155 (1195-203).

377

Srivastava S et al. Protein histidine phosphatase 1 negatively regulates CD4 T cells by inhibiting the K+ channel KCa3.1.
Proc. Natl. Acad. Sci. U.S.A., 2008 Sep 23 , 105 (14442-6).

378

Alper SL Let's look at cysts from both sides now.
Kidney Int., 2008 Sep , 74 (699-702).

379

Toyama K et al. The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans.
J. Clin. Invest., 2008 Sep , 118 (3025-37).

380

Duffy SM et al. Engagement of the EP2 prostanoid receptor closes the K+ channel KCa3.1 in human lung mast cells and attenuates their migration.
Eur. J. Immunol., 2008 Sep , 38 (2548-56).

381

Albaqumi M et al. KCa3.1 potassium channels are critical for cAMP-dependent chloride secretion and cyst growth in autosomal-dominant polycystic kidney disease.
Kidney Int., 2008 Sep , 74 (740-9).

382

Nie L et al. Molecular identity and functional properties of a novel T-type Ca2+ channel cloned from the sensory epithelia of the mouse inner ear.
J. Neurophysiol., 2008 Oct , 100 (2287-99).

383

Lin Z et al. A critical GxxxA motif in the gamma6 calcium channel subunit mediates its inhibitory effect on Cav3.1 calcium current.
J. Physiol. (Lond.), 2008 Nov 15 , 586 (5349-66).

384

Trinh NT et al. EGF and K+ channel activity control normal and cystic fibrosis bronchial epithelia repair.
Am. J. Physiol. Lung Cell Mol. Physiol., 2008 Nov , 295 (L866-80).

385

Tao R et al. Regulation of cell proliferation by intermediate-conductance Ca2+-activated potassium and volume-sensitive chloride channels in mouse mesenchymal stem cells.
Am. J. Physiol., Cell Physiol., 2008 Nov , 295 (C1409-16).

386

Dora KA et al. Modulation of endothelial cell KCa3.1 channels during endothelium-derived hyperpolarizing factor signaling in mesenteric resistance arteries.
Circ. Res., 2008 May 23 , 102 (1247-55).

387

Inagaki A et al. The CaV3.1 T-type Ca2+channel contributes to voltage-dependent calcium currents in rat outer hair cells.
Brain Res., 2008 Mar 27 , 1201 (68-77).

388

Lauf PK et al. Apparent intermediate K conductance channel hyposmotic activation in human lens epithelial cells.
Am. J. Physiol., Cell Physiol., 2008 Mar , 294 (C820-32).

389

Kawasaki T et al. CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci.
Mod. Pathol., 2008 Mar , 21 (245-55).

390

Nakamoto T et al. Apical maxi-K (KCa1.1) channels mediate K+ secretion by the mouse submandibular exocrine gland.
Am. J. Physiol., Cell Physiol., 2008 Mar , 294 (C810-9).

391

Chou CC et al. KCa3.1: target and marker for cancer, autoimmune disorder and vascular inflammation?
Expert Rev. Mol. Diagn., 2008 Mar , 8 (179-87).

392

Shumilina E et al. Blunted IgE-mediated activation of mast cells in mice lacking the Ca2+-activated K+ channel KCa3.1.
J. Immunol., 2008 Jun 15 , 180 (8040-7).

393

Lounsbury KM Preventing stenosis by local inhibition of KCa3.1: a finger on the phenotypic switch.
Arterioscler. Thromb. Vasc. Biol., 2008 Jun , 28 (1036-8).

394

Tharp DL et al. Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis.
Arterioscler. Thromb. Vasc. Biol., 2008 Jun , 28 (1084-9).

395

Bittner KC et al. The relationship between single-channel and whole-cell conductance in the T-type Ca2+ channel CaV3.1.
Biophys. J., 2008 Jul , 95 (931-41).

396

Taylor SR et al. Sequential shrinkage and swelling underlie P2X7-stimulated lymphocyte phosphatidylserine exposure and death.
J. Immunol., 2008 Jan 1 , 180 (300-8).

397

Kang HW et al. Distinct contributions of different structural regions to the current kinetics of the Cav3.3 T-type Ca2+ channel.
Biochim. Biophys. Acta, 2008 Dec , 1778 (2740-8).

398

Khan N et al. Permeation and gating in CaV3.1 (alpha1G) T-type calcium channels effects of Ca2+, Ba2+, Mg2+, and Na+.
J. Gen. Physiol., 2008 Aug , 132 (223-38).

399

Obejero-Paz CA et al. Ni2+ block of CaV3.1 (alpha1G) T-type calcium channels.
J. Gen. Physiol., 2008 Aug , 132 (239-50).

400

Gao Y et al. Role of S3 and S4 transmembrane domain charged amino acids in channel biogenesis and gating of KCa2.3 and KCa3.1.
J. Biol. Chem., 2008 Apr 4 , 283 (9049-59).

401

Na HS et al. Attenuated neuropathic pain in Cav3.1 null mice.
Mol. Cells, 2008 Apr 30 , 25 (242-6).

402

Kurejová M et al. Monovalent currents through the T-type Cav3.1 channels and their block by Mg2+.
Gen. Physiol. Biophys., 2007 Sep , 26 (234-9).

403

Hu L et al. Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes.
J. Immunol., 2007 Oct 1 , 179 (4563-70).

404

Deng XL et al. Cell cycle-dependent expression of potassium channels and cell proliferation in rat mesenchymal stem cells from bone marrow.
Cell Prolif., 2007 Oct , 40 (656-70).

405

Xie G et al. Forward genetic screen of mouse reveals dominant missense mutation in the P/Q-type voltage-dependent calcium channel, CACNA1A.
Genes Brain Behav., 2007 Nov , 6 (717-27).

406

Shepherd MC et al. KCa3.1 Ca2+ activated K+ channels regulate human airway smooth muscle proliferation.
Am. J. Respir. Cell Mol. Biol., 2007 Nov , 37 (525-31).

407

Tao R et al. Functional ion channels in mouse bone marrow mesenchymal stem cells.
Am. J. Physiol., Cell Physiol., 2007 Nov , 293 (C1561-7).

408

Singh B et al. Mutational analysis of CACNA1G in idiopathic generalized epilepsy. Mutation in brief #962. Online.
Hum. Mutat., 2007 May , 28 (524-5).

409

Matos JE et al. Role of cholinergic-activated KCa1.1 (BK), KCa3.1 (SK4) and KV7.1 (KCNQ1) channels in mouse colonic Cl- secretion.
Acta Physiol (Oxf), 2007 Mar , 189 (251-8).

410

Blanks AM et al. Characterization of the molecular and electrophysiological properties of the T-type calcium channel in human myometrium.
J. Physiol. (Lond.), 2007 Jun 15 , 581 (915-26).

411

Duffy SM et al. Adenosine closes the K+ channel KCa3.1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor.
Eur. J. Immunol., 2007 Jun , 37 (1653-62).

412

Hildebrand ME et al. Selective inhibition of Cav3.3 T-type calcium channels by Galphaq/11-coupled muscarinic acetylcholine receptors.
J. Biol. Chem., 2007 Jul 20 , 282 (21043-55).

413

Gaborit N et al. Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart.
J. Physiol. (Lond.), 2007 Jul 15 , 582 (675-93).

414

Ogino S et al. Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample.
J Mol Diagn, 2007 Jul , 9 (305-14).

415

Kaushal V et al. The Ca2+-activated K+ channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration.
J. Neurosci., 2007 Jan 3 , 27 (234-44).

416

Traboulsie A et al. Subunit-specific modulation of T-type calcium channels by zinc.
J. Physiol. (Lond.), 2007 Jan 1 , 578 (159-71).

417

Moritoki Y et al. AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers.
Hepatology, 2007 Feb , 45 (314-22).

418

Sun HS et al. Zn2+ sensitivity of high- and low-voltage activated calcium channels.
Biophys. J., 2007 Aug 15 , 93 (1175-83).

419

Nicolaou SA et al. The Ca(2+)-activated K(+) channel KCa3.1 compartmentalizes in the immunological synapse of human T lymphocytes.
Am. J. Physiol., Cell Physiol., 2007 Apr , 292 (C1431-9).

420

Zhou C et al. Cav3.1 (alpha1G) controls von Willebrand factor secretion in rat pulmonary microvascular endothelial cells.
Am. J. Physiol. Lung Cell Mol. Physiol., 2007 Apr , 292 (L833-44).

421

Klein H et al. Structural determinants of the closed KCa3.1 channel pore in relation to channel gating: results from a substituted cysteine accessibility analysis.
J. Gen. Physiol., 2007 Apr , 129 (299-315).

422

Wulff H et al. Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications.
Curr. Med. Chem., 2007 , 14 (1437-57).

423

Deng XL et al. Properties of ion channels in rabbit mesenchymal stem cells from bone marrow.
Biochem. Biophys. Res. Commun., 2006 Sep 15 , 348 (301-9).

424

Fleming I Realizing its potential: the intermediate conductance Ca2+-activated K+ channel (KCa3.1) and the regulation of blood pressure.
Circ. Res., 2006 Sep 1 , 99 (462-4).

425

Nordskog BK et al. Diurnal gene expression patterns of T-type calcium channels and their modulation by ethanol.
Neuroscience, 2006 Sep 1 , 141 (1365-73).

426

Qiu J et al. Estrogen upregulates T-type calcium channels in the hypothalamus and pituitary.
J. Neurosci., 2006 Oct 25 , 26 (11072-82).

427

Choudhury P et al. Specificity of the myotubularin family of phosphatidylinositol-3-phosphatase is determined by the PH/GRAM domain.
J. Biol. Chem., 2006 Oct 20 , 281 (31762-9).

428

Cruse G et al. Functional KCa3.1 K+ channels are required for human lung mast cell migration.
Thorax, 2006 Oct , 61 (880-5).

429

Yang SN et al. The role of voltage-gated calcium channels in pancreatic beta-cell physiology and pathophysiology.
Endocr. Rev., 2006 Oct , 27 (621-76).

430

Vinet J et al. Expression pattern of voltage-dependent calcium channel subunits in hippocampal inhibitory neurons in mice.
Neuroscience, 2006 Nov 17 , 143 (189-212).

431

Avila T et al. Transforming growth factor-beta1 and bone morphogenetic protein-2 downregulate CaV3.1 channel expression in mouse C2C12 myoblasts.
J. Cell. Physiol., 2006 Nov , 209 (448-56).

432

Mangoni ME et al. Bradycardia and slowing of the atrioventricular conduction in mice lacking CaV3.1/alpha1G T-type calcium channels.
Circ. Res., 2006 Jun 9 , 98 (1422-30).

433

Srivastava S et al. Phosphatidylinositol 3-phosphate indirectly activates KCa3.1 via 14 amino acids in the carboxy terminus of KCa3.1.
Mol. Biol. Cell, 2006 Jan , 17 (146-54).

434

Thompson J et al. Membrane-delimited inhibition of maxi-K channel activity by the intermediate conductance Ca2+-activated K channel.
J. Gen. Physiol., 2006 Feb , 127 (159-69).

435

Mizuta E et al. Delayed onset of beating and decreased expression of T-type Ca2+ channel in mouse ES cell-derived cardiocytes carrying human chromosome 21.
Biochem. Biophys. Res. Commun., 2006 Dec 8 , 351 (126-32).

436

Srivastava S et al. Histidine phosphorylation of the potassium channel KCa3.1 by nucleoside diphosphate kinase B is required for activation of KCa3.1 and CD4 T cells.
Mol. Cell, 2006 Dec 8 , 24 (665-75).

437

Park JY et al. Activation of protein kinase C augments T-type Ca2+ channel activity without changing channel surface density.
J. Physiol. (Lond.), 2006 Dec 1 , 577 (513-23).

438

Hamid J et al. Determinants of the differential gating properties of Cav3.1 and Cav3.3 T-type channels: a role of domain IV?
Neuroscience, 2006 Dec , 143 (717-28).

439

Zhou C et al. T-type calcium channels in pulmonary vascular endothelium.
, 2006 Dec , 13 (645-56).

440

Wen XJ et al. Intrathecal administration of Cav3.2 and Cav3.3 antisense oligonucleotide reverses tactile allodynia and thermal hyperalgesia in rats following chronic compression of dorsal root of ganglion.
Acta Pharmacol. Sin., 2006 Dec , 27 (1547-52).

441

Perez-Reyes E et al. Molecular biology of T-type calcium channels.
CNS Neurol Disord Drug Targets, 2006 Dec , 5 (605-9).

442

Lambert RC et al. Modulation of neuronal T-type calcium channels.
CNS Neurol Disord Drug Targets, 2006 Dec , 5 (611-27).

443

Emerick MC et al. Profiling the array of Ca(v)3.1 variants from the human T-type calcium channel gene CACNA1G: alternative structures, developmental expression, and biophysical variations.
Proteins, 2006 Aug 1 , 64 (320-42).

444

Perez-Reyes E Molecular characterization of T-type calcium channels.
Cell Calcium, 2006 Aug , 40 (89-96).

445

Vassort G et al. Role of T-type Ca2+ channels in the heart.
Cell Calcium, 2006 Aug , 40 (205-20).

446

Talavera K et al. Biophysics and structure-function relationship of T-type Ca2+ channels.
Cell Calcium, 2006 Aug , 40 (97-114).

447

Crunelli V et al. Thalamic T-type Ca2+ channels and NREM sleep.
Cell Calcium, 2006 Aug , 40 (175-90).

448

Lory P et al. T-type calcium channels in differentiation and proliferation.
Cell Calcium, 2006 Aug , 40 (135-46).

449

Chemin J et al. Molecular pathways underlying the modulation of T-type calcium channels by neurotransmitters and hormones.
Cell Calcium, 2006 Aug , 40 (121-34).

450

Srivastava S et al. Phosphatidylinositol-3 phosphatase myotubularin-related protein 6 negatively regulates CD4 T cells.
Mol. Cell. Biol., 2006 Aug , 26 (5595-602).

451

Tarabova B et al. Inorganic mercury and methylmercury inhibit the Cav3.1 channel expressed in human embryonic kidney 293 cells by different mechanisms.
J. Pharmacol. Exp. Ther., 2006 Apr , 317 (418-27).

452

Lacinova L et al. Gating of the expressed T-type Cav3.1 calcium channels is modulated by Ca2+.
Acta Physiol (Oxf), 2006 Apr , 186 (249-60).

453

Li M et al. Towards selective antagonists of T-type calcium channels: design, characterization and potential applications of NNC 55-0396.
, 2005 Summer , 23 (173-96).

454

Mizuta E et al. Subtype switching of T-type Ca 2+ channels from Cav3.2 to Cav3.1 during differentiation of embryonic stem cells to cardiac cell lineage.
Circ. J., 2005 Oct , 69 (1284-9).

455

Kuwahara K et al. Pathophysiological significance of T-type Ca2+ channels: transcriptional regulation of T-type Ca2+ channel--regulation of CACNA1H by neuron-restrictive silencer factor.
J. Pharmacol. Sci., 2005 Nov , 99 (211-3).

456

Srivastava S et al. The phosphatidylinositol 3-phosphate phosphatase myotubularin- related protein 6 (MTMR6) is a negative regulator of the Ca2+-activated K+ channel KCa3.1.
Mol. Cell. Biol., 2005 May , 25 (3630-8).

457

Gaborit N et al. Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation.
Circulation, 2005 Jul 26 , 112 (471-81).

458

Bourinet E et al. Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception.
EMBO J., 2005 Jan 26 , 24 (315-24).

459

Marionneau C et al. Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart.
J. Physiol. (Lond.), 2005 Jan 1 , 562 (223-34).

460

Yang SN et al. Beta-cell CaV channel regulation in physiology and pathophysiology.
Am. J. Physiol. Endocrinol. Metab., 2005 Jan , 288 (E16-28).

461

Nahm SS et al. Differential expression of T-type calcium channels in P/Q-type calcium channel mutant mice with ataxia and absence epilepsy.
J. Neurobiol., 2005 Feb 15 , 62 (352-60).

462

Anderson MP et al. Thalamic Cav3.1 T-type Ca2+ channel plays a crucial role in stabilizing sleep.
Proc. Natl. Acad. Sci. U.S.A., 2005 Feb 1 , 102 (1743-8).

463

Larsen JK et al. Disruption of growth hormone secretion alters Ca2+ current density and expression of Ca2+ channel and insulin-like growth factor genes in rat atria.
Am. J. Physiol. Heart Circ. Physiol., 2005 Feb , 288 (H829-38).

464

Léoni AL et al. Chronic heart rate reduction remodels ion channel transcripts in the mouse sinoatrial node but not in the ventricle.
Physiol. Genomics, 2005 Dec 14 , 24 (4-12).

465

Rodman DM et al. The low-voltage-activated calcium channel CAV3.1 controls proliferation of human pulmonary artery myocytes.
Chest, 2005 Dec , 128 (581S-582S).

466

Choi J et al. T-type calcium channel trigger p21ras signaling pathway to ERK in Cav3.1-expressed HEK293 cells.
Brain Res., 2005 Aug 23 , 1054 (22-9).

467

Banderali U et al. New insights on the voltage dependence of the KCa3.1 channel block by internal TBA.
J. Gen. Physiol., 2004 Oct , 124 (333-48).

468

Li J et al. Roles of molecular regions in determining differences between voltage dependence of activation of CaV3.1 and CaV1.2 calcium channels.
J. Biol. Chem., 2004 Jun 25 , 279 (26858-67).

469

Leresche N et al. Paradoxical potentiation of neuronal T-type Ca2+ current by ATP at resting membrane potential.
J. Neurosci., 2004 Jun 16 , 24 (5592-602).

470

Mudado MA et al. CaV 3.1 and CaV 3.3 account for T-type Ca2+ current in GH3 cells.
Braz. J. Med. Biol. Res., 2004 Jun , 37 (929-35).

471

Stamboulian S et al. Biophysical and pharmacological characterization of spermatogenic T-type calcium current in mice lacking the CaV3.1 (alpha1G) calcium channel: CaV3.2 (alpha1H) is the main functional calcium channel in wild-type spermatogenic cells.
J. Cell. Physiol., 2004 Jul , 200 (116-24).

472

Hansen JP et al. Calcium channel gamma6 subunits are unique modulators of low voltage-activated (Cav3.1) calcium current.
J. Mol. Cell. Cardiol., 2004 Dec , 37 (1147-58).

473

Harkins AB et al. Expression of recombinant calcium channels support secretion in a mouse pheochromocytoma cell line.
J. Neurophysiol., 2003 Oct , 90 (2325-33).

474

Welsby PJ et al. A mechanism for the direct regulation of T-type calcium channels by Ca2+/calmodulin-dependent kinase II.
J. Neurosci., 2003 Nov 5 , 23 (10116-21).

475

Kim SG et al. Epigenetic and genetic alterations in duodenal carcinomas are distinct from biliary and ampullary carcinomas.
Gastroenterology, 2003 May , 124 (1300-10).

476

Bertolesi GE et al. Regulation of alpha1G T-type calcium channel gene (CACNA1G) expression during neuronal differentiation.
Eur. J. Neurosci., 2003 May , 17 (1802-10).

477

Delisle BP et al. Monovalent cations contribute to T-type calcium channel (Cav3.1 and Cav3.2) selectivity.
J. Membr. Biol., 2003 Jun 1 , 193 (185-94).

478

Talavera K et al. Pore structure influences gating properties of the T-type Ca2+ channel alpha1G.
J. Gen. Physiol., 2003 Jun , 121 (529-40).

479

Talavera K et al. Extracellular Ca2+ modulates the effects of protons on gating and conduction properties of the T-type Ca2+ channel alpha1G (CaV3.1).
J. Gen. Physiol., 2003 Jun , 121 (511-28).

480

Ferron L et al. Angiotensin II signaling pathways mediate expression of cardiac T-type calcium channels.
Circ. Res., 2003 Dec 12 , 93 (1241-8).

481

Zhang YM et al. Characterization and regulation of T-type Ca2+ channels in embryonic stem cell-derived cardiomyocytes.
Am. J. Physiol. Heart Circ. Physiol., 2003 Dec , 285 (H2770-9).

482

Lee SC et al. Availability of low-threshold Ca2+ current in retinal ganglion cells.
J. Neurophysiol., 2003 Dec , 90 (3888-901).

483

Yunker AM et al. Low-voltage-activated ("T-Type") calcium channels in review.
J. Bioenerg. Biomembr., 2003 Dec , 35 (533-75).

484

Yunker AM Modulation and pharmacology of low voltage-activated ("T-Type") calcium channels.
J. Bioenerg. Biomembr., 2003 Dec , 35 (577-98).

485

Gromová P et al. Inhibition of Cav3.1 channel by silver ions.
Gen. Physiol. Biophys., 2003 Dec , 22 (515-23).

486

Wu S et al. Cav3.1 (alpha1G) T-type Ca2+ channels mediate vaso-occlusion of sickled erythrocytes in lung microcirculation.
Circ. Res., 2003 Aug 22 , 93 (346-53).

487

Yunker AM et al. Immunological characterization of T-type voltage-dependent calcium channel CaV3.1 (alpha 1G) and CaV3.3 (alpha 1I) isoforms reveal differences in their localization, expression, and neural development.
Neuroscience, 2003 , 117 (321-35).

488

Bergquist F et al. Influence of R-type (Cav2.3) and t-type (Cav3.1-3.3) antagonists on nigral somatodendritic dopamine release measured by microdialysis.
Neuroscience, 2003 , 120 (757-64).

489

Chemin J et al. [Functional specificity of T-type calcium channels and their roles in neuronal differentiation]
J. Soc. Biol., 2003 , 197 (235-47).

490

Lacinová L et al. Gating of the expressed Cav3.1 calcium channel.
FEBS Lett., 2002 Nov 6 , 531 (235-40).

491

Beedle AM et al. Inhibition of transiently expressed low- and high-voltage-activated calcium channels by trivalent metal cations.
J. Membr. Biol., 2002 Jun 1 , 187 (225-38).

492

Zhang Y et al. Mutations in high-voltage-activated calcium channel genes stimulate low-voltage-activated currents in mouse thalamic relay neurons.
J. Neurosci., 2002 Aug 1 , 22 (6362-71).

493

Sakata Y et al. Analysis of Ca(2+) currents in spermatocytes from mice lacking Ca(v)2.3 (alpha(1E)) Ca(2+) channel.
Biochem. Biophys. Res. Commun., 2001 Nov 9 , 288 (1032-6).

494

Monteil A et al. Molecular and functional properties of the human alpha(1G) subunit that forms T-type calcium channels.
J. Biol. Chem., 2000 Mar 3 , 275 (6090-100).

495

Cribbs LL et al. Molecular cloning and functional expression of Ca(v)3.1c, a T-type calcium channel from human brain.
FEBS Lett., 2000 Jan 21 , 466 (54-8).

496

Ueki T et al. Hypermethylation of multiple genes in pancreatic adenocarcinoma.
Cancer Res., 2000 Apr 1 , 60 (1835-9).

497

Toyota M et al. Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5' CpG island in human tumors.
Cancer Res., 1999 Sep 15 , 59 (4535-41).

498

Mittman S et al. Structure and alternative splicing of the gene encoding alpha1G, a human brain T calcium channel alpha1 subunit.
Neurosci. Lett., 1999 Oct 29 , 274 (143-6).

499

Perez-Reyes E et al. Molecular characterization of two members of the T-type calcium channel family.
Ann. N. Y. Acad. Sci., 1999 Apr 30 , 868 (131-43).